MiR-888 in MCF-7 Side Population Sphere Cells Directly Targets E-cadherin

Journal of Genetics and Genomics

Volumn 41, Issue 1, 2014, Pages 35-42

  Huang, Shengjian ^a   Cai, Ming ^b   Zheng, Yinghui ^a   Zhou, Longhai ^a   Wang, Qiang ^b   Chen, Liangbiao ^a  

^a INSTITUTE OF GENETICS AND DEVELOPMENTAL BIOLOGY   (China)

^b 309TH HOSPITAL OF PLA   (China)

Author keywords

Adherens junction; Cancer metastasis; Cancer stem cell; MicroRNA; Side population

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 139; MICRORNA 217; MICRORNA 296; MICRORNA 455; MICRORNA 491; MICRORNA 494; MICRORNA 498; MICRORNA 501; MICRORNA 518A; MICRORNA 532; MICRORNA 557; MICRORNA 564; MICRORNA 572; MICRORNA 575; MICRORNA 602; MICRORNA 612; MICRORNA 615; MICRORNA 638; MICRORNA 639; MICRORNA 663; MICRORNA 675; MICRORNA 744; MICRORNA 768; MICRORNA 888; MICRORNA 921; MICRORNA423; PROTEIN CDC42; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; BREAST CANCER; CANCER STEM CELL; CARCINOGENICITY; CELL POPULATION; CELL STRAIN MCF 7; DOWN REGULATION; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; TUMOR SPHEROID; UPREGULATION; WESTERN BLOTTING;

ADHERENS JUNCTION; CANCER METASTASIS; CANCER STEM CELL; MICRORNA; SIDE POPULATION;

ADHERENS JUNCTIONS; BREAST NEOPLASMS; CADHERINS; CELL LINE, TUMOR; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; RNA, MESSENGER; SIDE-POPULATION CELLS;

EID: 84893639195     PISSN: 16738527     EISSN: 18735533     Source Type: Journal    
DOI: 10.1016/j.jgg.2013.12.002     Document Type: Article

References (36)

1. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 2003, 100:3983-3988.
2. Calin G.A., Croce C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 2006, 6:857-866.
3. Campbell L.L., Polyak K. Breast tumor heterogeneity: cancer stem cells or clonal evolution?. Cell Cycle 2007, 6:2332-2338.
4. Chiba T., Kita K., Zheng Y.W., Yokosuka O., Saisho H., Iwama A., Nakauchi H., Taniguchi H. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology 2006, 44:240-251.
5. Engelmann K., Shen H., Finn O.J. MCF7 side population cells with characteristics of cancer stem/progenitor cells express the tumor antigen MUC1. Cancer Res. 2008, 68:2419-2426.
6. Fong M.Y., Kakar S.S. The role of cancer stem cells and the side population in epithelial ovarian cancer. Histol. Histopathol. 2010, 25:113-120.
7. Garzon R., Marcucci G., Croce C.M. Targeting microRNAs in cancer: rationale, strategies and challenges. Nat. Rev. Drug Discov. 2010, 9:775-789.
8. Goodell M.A., Brose K., Paradis G., Conner A.S., Mulligan R.C. Isolation and functional properties of murine hematopoietic stem cells that are replicating invivo. J. Exp. Med. 1996, 183:1797-1806.
9. Heppner G.H. Tumor heterogeneity. Cancer Res. 1984, 44:2259-2265.
10. Hermann P.C., Huber S.L., Herrler T., Aicher A., Ellwart J.W., Guba M., Bruns C.J., Heeschen C. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007, 1:313-323.
11. Hermiston M.L., Wong M.H., Gordon J.I. Forced expression of E-cadherin in the mouse intestinal epithelium slows cell migration and provides evidence for nonautonomous regulation of cell fate in a self-renewing system. Genes Dev. 1996, 10:985-996.
12. Ho M.M., Ng A.V., Lam S., Hung J.Y. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res. 2007, 67:4827-4833.
13. Huang B., Huang Y.J., Yao Z.J., Chen X., Guo S.J., Mao X.P., Wang D.H., Chen J.X., Qiu S.P. Cancer stem cell-like side population cells in clear cell renal cell carcinoma cell line 769P. PLoS ONE 2013, 8:e68293.
14. Jordan C.T., Guzman M.L., Noble M. Cancer stem cells. N. Engl. J. Med. 2006, 355:1253-1261.
15. Kim S.H., Li Z., Sacks D.B. E-cadherin-mediated cell-cell attachment activates Cdc42. J. Biol. Chem. 2000, 275:36999-37005.
16. Korpal M., Lee E.S., Hu G., Kang Y. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J. Biol. Chem. 2008, 283:14910-14914.
17. Li F., Tiede B., Massagué J., Kang Y. Beyond tumorigenesis: cancer stem cells in metastasis. Cell Res. 2006, 17:3-14.
18. Liu C., Kelnar K., Liu B., Chen X., Calhoun-Davis T., Li H., Patrawala L., Yan H., Jeter C., Honorio S. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat. Med. 2011, 17:211-215.
19. Lynch H.T., Watson P., Lynch J.F., Conway T.A., Fili M. Hereditary ovarian cancer: heterogeneity in age at onset. Cancer 1993, 71:573-581.
20. Ma L., Young J., Prabhala H., Pan E., Mestdagh P., Muth D., Teruya-Feldstein J., Reinhardt F., Onder T.T., Valastyan S. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat. Cell Biol. 2010, 12:247-256.
21. Marusyk A., Polyak K. Tumor heterogeneity: causes and consequences. Biochim. Biophys. Acta. 2010, 1805:105-117.
22. McLachlan R.W. Protein tyrosine phosphatase activity is necessary for E-cadherin-activated Src signaling. Cytoskeleton 2011, 68:32-43.
23. Obernosterer G., Martinez J., Alenius M. Locked nucleic acid-based in situ detection of microRNAs in mouse tissue sections. Nat. Protoc. 2007, 2:1508-1514.
24. Pece S., Tosoni D., Confalonieri S., Mazzarol G., Vecchi M., Ronzoni S., Bernard L., Viale G., Pelicci P.G., Di Fiore P.P. Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell 2010, 140:62-73.
25. Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111.
26. Roggli V.L., Vollmer R.T., Greenberg S.D., McGavran M.H., Spjut H.J., Yesner R. Lung cancer heterogeneity: a blinded and randomized study of 100 consecutive cases. Hum. Pathol. 1985, 16:569-579.
27. Salcido C., Larochelle A., Taylor B., Dunbar C., Varticovski L. Molecular characterisation of side population cells with cancer stem cell-like characteristics in small-cell lung cancer. Br. J. Cancer 2010, 102:1636-1644.
28. Sell S. Heterogeneity and plasticity of hepatocyte lineage cells. Hepatology 2001, 33:738-750.
29. Shi M., Guo N. MicroRNA expression and its implications for the diagnosis and therapeutic strategies of breast cancer. Cancer Treat. Rev. 2009, 35:328-334.
30. Shipitsin M., Campbell L.L., Argani P., Weremowicz S., Bloushtain-Qimron N., Yao J., Nikolskaya T., Serebryiskaya T., Beroukhim R., Hu M. Molecular definition of breast tumor heterogeneity. Cancer Cell 2007, 11:259-273.
31. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., Dirks P.B. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401.
32. Symmans W.F., Liu J., Knowles D.M., Inghirami G. Breast cancer heterogeneity: evaluation of clonality in primary and metastatic lesions. Hum. Pathol. 1995, 26:210-216.
33. Thomson J.M., Parker J., Perou C.M., Hammond S.M. A custom microarray platform for analysis of microRNA gene expression. Nat. Methods 2004, 1:47-53.
34. Visvader J.E. Cells of origin in cancer. Nature 2011, 469:314-322.
35. Wang H.J., Guo Y.Q., Tan G., Dong L., Cheng L., Li K.J., Wang Z.Y., Luo H.F. MiR-125b regulates side population in breast cancer and confers a chemoresistant phenotype. J. Cell. Biochem. 2013, 114:2248-2257.
36. Wang Y., Yu Y., Tsuyada A., Ren X., Wu X., Stubblefield K., Rankin-Gee E.K., Wang S.E. Transforming growth factor-β regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM. Oncogene 2010, 30:1470-1480.